Chemotherapeutic drugs change actin skeleton organization and the expression of β-thymosins in human breast cancer cells

Journal of Cancer Research and Clinical Oncology

Volumn 128, Issue 5, 2002, Pages 247-256

  Otto, A ^a,b   Muller C ^a   Huff, T ^a   Hannappel, E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

thymosins; Actin skeleton; Breast cancer cells; Cisplatin; Tamoxifen

Indexed keywords

ACTIN; ANTIINFECTIVE AGENT; CISPLATIN; DYE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; F ACTIN; MESSENGER RNA; PHALLOIDIN; TAMOXIFEN; THYMOSIN; THYMOSIN 15; THYMOSIN BETA10; THYMOSIN BETA4; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL CONTACT; CELL STRAIN MCF 7; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOARCHITECTURE; DRUG EFFECT; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE; HUMAN; HUMAN CELL; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; RIBONUCLEASE PROTECTION ASSAY; SERUM; STAINING; TISSUE LEVEL;

ACTINS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CYTOSKELETON; FEMALE; HUMANS; RECEPTORS, ESTROGEN; RNA, MESSENGER; THYMOSIN; TUMOR CELLS, CULTURED;

EID: 0036272150     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-002-0332-7     Document Type: Article

References (43)

1. In vivo functions of actin-binding proteins
2. Thymosin beta 15: A novel regulator of tumor cell motility upregulated in metastatic prostate cancer
3. Thymosin beta15 expression in tumor cell lines with varying metastatic potential
4. Thymosin beta 4 sequesters the majority of G-actin in resting human polymorphonuclear leukocytes
5. Western immunoblotting and enzymatic activity analysis of cathepsin D in human breast cancer cell lines of different invasive potential. Regulation by 17beta-estradiol, tamoxifen and ICI 182,780
6. Concomitant alterations of microfilaments and microtubules in human epithelial cells (HBL-100) in relation to their malignant conversion
7. Cell matrix adhesions and localization of the vitronectin receptor in MCF-7 human mammary carcinoma cells
8. 17-beta-Estradiol induced alterations of cell-matrix and intercellular adhesions in a human mammary carcinoma cell line
9. Thymosin beta 10, a new analog of thymosin beta 4 in mammalian tissues
10. The cytoskeleton in cancer cells in animals and humans
11. Estrogen-stimulation of postconfluent cell accumulation and foci formation of human MCF-7 breast cancer cells
12. Localization and quantitation of expression of the cell motility-related protein thymosin beta15 in human breast tissue
13. Co-ordinate regulation of the cytoskeleton in 3T3 cells overexpressing thymosin-beta4
14. Differential expression of thymosin genes in human tumors and in the developing human kidney
15. Thymosin beta 10 levels in developing human brain and its regulation by retinoic acid in the HTB-10 neuroblastoma
16. One-step procedure for the determination of thymosin beta 4 in small tissue samples and its separation from other thymosin beta 4-like peptides by high-pressure liquid chromatography
17. Biosynthesis rates and content of thymosin beta 4 in cell lines
18. Determination of thymosin beta 4 in human blood cells and serum
19. Isolation and characterization of thymosin beta 9 Met from pork spleen
20. HPLC and post-column derivatization with fluorescamine isolation of actin-sequestering β-thymosins by reversed-phase HPLC
21. Thymosin beta(4) serves as a glutaminyl substrate of transglutaminase. Labeling with fluorescent dansylcadaverine does not abolish interaction with G-actin
22. beta-Thymosins, small acidic peptides with multiple functions
23. Induction of necrosis by zinc in prostate carcinoma cells and identification of proteins increased in association with this induction
24. Developmental regulation of beta-thymosins in the rat central nervous system
25. Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines
26. Small actin-binding proteins: The beta-thymosin family
27. Dissociation of estrogenic and cytotoxic properties of an estrogen receptor-binding platinum complex in human breast cancer cell lines
28. Cell-cycle arrest, micronucleus formation, and cell death in growth inhibition of MCF-7 breast cancer cells by tamoxifen and cisplatin
29. Changes in the levels of β-thymosins in a human breast cancer cell line under various conditions of growth
30. Changes in the level of β-thymosins, small actin-binding proteisn, in tumor cells: A possible role in growth and malignancy
31. Patterns of organization of actin and myosin in normal and transformed cultured cells
32. Actin and actin-binding proteins. A critical evaluation of mechanisms and functions
33. Thymosin β4 (Fx peptide) is a potent regulator of actin polymerization in living cells
34. Increasing intracellular concentrations of thymosin beta 4 in PtK2 cells: Effects on stress fibers, cytokinesis, and cell spreading
35. Thymosin beta-10 gene overexpression is a general event in human carcinogenesis
36. Cell-cycle-regulated expression of thymosin beta 4 in thymocytes
37. β-Thymosins are not simple actin monomer buffering proteins. Insight from overexpression studies
38. Tamoxifen induces accumulation of MCF-7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle
39. Preliminary findings on the expression of thymosin beta-10 in human breast cancer
40. Thymosin beta-4 expression is correlated with metastatic capacity of colorectal carcinomas
41. Thymosin beta 10 and thymosin beta 4 are both actin monomer sequestering proteins
42. Effects of thymosin beta 4 and thymosin beta 10 on actin structures in living cells